CD34 and acute myeloid leukemia: Unlike the normal myeloblasts, however, CD34+ myeloblasts from AML M4/M5 expressed higher levels of SOX2 than those in NBM (MMI SOX2: 38.5 ± 6.4 vs. 11.3 ± 0.6, p = 0.0257).